Skip to main content
Top
Published in: International Cancer Conference Journal 2/2019

01-04-2019 | Lymphoma | Case report

Mass-forming mucosa-associated lymphoid tissue lymphoma of the cecum treated by laparoscopy-assisted bowel resection

Authors: Yuki Nakamura, Kenji Matsuda, Shozo Yokoyama, Koichi Tamura, Yasuyuki Mitani, Hiromitsu Iwamoto, Yuki Mizumoto, Daisuke Murakami, Masakazu Fujimoto, Hiroki Yamaue

Published in: International Cancer Conference Journal | Issue 2/2019

Login to get access

Abstract

Colonic mucosa-associated lymphoid tissue (MALT) lymphoma is very rare, especially those which form a mass. Although the characteristics and treatment methods of gastric MALT lymphomas are well established, those of colonic MALT lymphomas have been insufficiently described. Here, we report a case of mass-forming cecal MALT lymphoma that was successfully treated by laparoscopy-assisted bowel resection. A 60-year-old woman with right lower abdominal pain and a palpable tumor was referred to our hospital. Colonoscopy showed a smooth elevated submucosal tumor-like lesion in the cecum. Histological and immunochemical findings were consistent with MALT lymphoma. Serum tumor marker levels were within normal range. Enhanced abdominal computed tomography showed a large tumor 55 mm in diameter in the cecum and edema of a few paracolic lymph nodes. The tumor was diagnosed as cecal MALT lymphoma classified as stage II1 by Lugano classification, and laparoscopy-assisted ileocecal resection was performed. The postoperative course was uneventful and the patient underwent eradication therapy for Helicobacter pylori. A year after the operation she has had no recurrence. In patients with mass-forming colonic MALT lymphoma without dissemination, surgical resection may be a feasible treatment.
Literature
1.
go back to reference Isaacson PG, Chott A, Nakamura S et al (2008) Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: Swerdlow SH, Campo E, Harris NL et al (ed) WHO classification of tumors of haematopoietic and lymphoid tissues. IARC, Lyon, pp 214–217 Isaacson PG, Chott A, Nakamura S et al (2008) Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: Swerdlow SH, Campo E, Harris NL et al (ed) WHO classification of tumors of haematopoietic and lymphoid tissues. IARC, Lyon, pp 214–217
2.
go back to reference Hahn JS, Kim YS, Lee YC et al (2003) Eleven-year experience of low grade lymphoma in Korea (based on REAL classification). Yonsei Med J 44:757–770CrossRefPubMed Hahn JS, Kim YS, Lee YC et al (2003) Eleven-year experience of low grade lymphoma in Korea (based on REAL classification). Yonsei Med J 44:757–770CrossRefPubMed
4.
go back to reference Matsuo S, Mizuta Y, Hayashi T et al (2006) Mucosa-associated lymphoid tissue lymphoma of the transverse colon: a case report. World J Gastroenterol 12:5573–5576CrossRefPubMedPubMedCentral Matsuo S, Mizuta Y, Hayashi T et al (2006) Mucosa-associated lymphoid tissue lymphoma of the transverse colon: a case report. World J Gastroenterol 12:5573–5576CrossRefPubMedPubMedCentral
5.
go back to reference Kelley SR (2017) Mucosa-associated lymphoid tissue (MALT) variant of primary rectal lymphoma: a review of the English literature. Int J Colorectal Dis 32:295–304CrossRefPubMed Kelley SR (2017) Mucosa-associated lymphoid tissue (MALT) variant of primary rectal lymphoma: a review of the English literature. Int J Colorectal Dis 32:295–304CrossRefPubMed
6.
go back to reference Rohatiner A, d’Amore F, Coiffier B et al (1994) Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 5:397–400CrossRefPubMed Rohatiner A, d’Amore F, Coiffier B et al (1994) Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 5:397–400CrossRefPubMed
7.
go back to reference Koch P, del Valle F, Berdel WE et al (2001) Primary gastrointestinal non-Hodgkin’s lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol 19:3861–3873CrossRefPubMed Koch P, del Valle F, Berdel WE et al (2001) Primary gastrointestinal non-Hodgkin’s lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol 19:3861–3873CrossRefPubMed
9.
go back to reference Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR et al (1991) Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338:1175–1176CrossRefPubMed Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR et al (1991) Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338:1175–1176CrossRefPubMed
10.
go back to reference Montalban C, Santon A, Boixeda D et al (2001) Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up. Haematologica 86:609–617PubMed Montalban C, Santon A, Boixeda D et al (2001) Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up. Haematologica 86:609–617PubMed
11.
go back to reference Matsumoto T, Iida M, Shimizu M (1997) Regression of mucosa-associated lymphoid-tissue lymphoma of rectum after eradication of Helicobacter pylori. Lancet 350:115–116CrossRefPubMed Matsumoto T, Iida M, Shimizu M (1997) Regression of mucosa-associated lymphoid-tissue lymphoma of rectum after eradication of Helicobacter pylori. Lancet 350:115–116CrossRefPubMed
12.
go back to reference Raderer M, Pfeffel F, Pohl G et al (2000) Regression of colonic low grade B cell lymphoma of the mucosa associated lymphoid tissue type after eradication of Helicobacter pylori. Gut 46:133–135CrossRefPubMedPubMedCentral Raderer M, Pfeffel F, Pohl G et al (2000) Regression of colonic low grade B cell lymphoma of the mucosa associated lymphoid tissue type after eradication of Helicobacter pylori. Gut 46:133–135CrossRefPubMedPubMedCentral
13.
go back to reference Grünberger B, Wöhrer S, Streubel B et al (2006) Antibiotic treatment is not effective in patients infected with Helicobacter pylori suffering from extragastric MALT lymphoma. J Clin Oncol 24:1370–1375CrossRefPubMed Grünberger B, Wöhrer S, Streubel B et al (2006) Antibiotic treatment is not effective in patients infected with Helicobacter pylori suffering from extragastric MALT lymphoma. J Clin Oncol 24:1370–1375CrossRefPubMed
14.
go back to reference Takada M, Ichihara T, Fukumoto S et al (2003) Laparoscopy-assisted colon resection for mucosa-associated lymphoid tissue (MALT) lymphoma in the cecum. Hepatogastroenterology 50:1003–1005PubMed Takada M, Ichihara T, Fukumoto S et al (2003) Laparoscopy-assisted colon resection for mucosa-associated lymphoid tissue (MALT) lymphoma in the cecum. Hepatogastroenterology 50:1003–1005PubMed
15.
go back to reference Hasegawa N, Kato K, Yamada K et al (2000) Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) of the sigmoid colon. Gastrointest Endosc 52:802–804CrossRefPubMed Hasegawa N, Kato K, Yamada K et al (2000) Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) of the sigmoid colon. Gastrointest Endosc 52:802–804CrossRefPubMed
16.
go back to reference Tanimoto A, Hamada T, Yamamoto T et al (2002) MALT lymphoma with extreme plasma cell differentiation of the rectum. Am J Gastroenterol 97:1860–1862CrossRefPubMed Tanimoto A, Hamada T, Yamamoto T et al (2002) MALT lymphoma with extreme plasma cell differentiation of the rectum. Am J Gastroenterol 97:1860–1862CrossRefPubMed
17.
go back to reference Jain V, Misra S, Ahmad F et al (2013) MALT lymphoma of caecum presenting as acute intestinal obstruction: a case report. Indian J Surg 75:286–289CrossRefPubMed Jain V, Misra S, Ahmad F et al (2013) MALT lymphoma of caecum presenting as acute intestinal obstruction: a case report. Indian J Surg 75:286–289CrossRefPubMed
18.
go back to reference Seo SW, Lee SH, Lee DJ et al (2014) Colonic mucosa-associated lymphoid tissue lymphoma identified by chromoendoscopy. World J Gastroenterol 20:18487–18494CrossRefPubMedPubMedCentral Seo SW, Lee SH, Lee DJ et al (2014) Colonic mucosa-associated lymphoid tissue lymphoma identified by chromoendoscopy. World J Gastroenterol 20:18487–18494CrossRefPubMedPubMedCentral
19.
go back to reference Palo S, Biligi DS (2016) A unique presentation of primary intestinal MALT lymphoma as multiple lymphomatous polyposis. J Clin Diagn Res 10:16–18 Palo S, Biligi DS (2016) A unique presentation of primary intestinal MALT lymphoma as multiple lymphomatous polyposis. J Clin Diagn Res 10:16–18
20.
go back to reference Raderer M, Streubel B, Woehrer S et al (2005) High relapse rate in patients with MALT lymphoma warrants lifelong follow-up. Clin Cancer Res 11:3349–3352CrossRefPubMed Raderer M, Streubel B, Woehrer S et al (2005) High relapse rate in patients with MALT lymphoma warrants lifelong follow-up. Clin Cancer Res 11:3349–3352CrossRefPubMed
Metadata
Title
Mass-forming mucosa-associated lymphoid tissue lymphoma of the cecum treated by laparoscopy-assisted bowel resection
Authors
Yuki Nakamura
Kenji Matsuda
Shozo Yokoyama
Koichi Tamura
Yasuyuki Mitani
Hiromitsu Iwamoto
Yuki Mizumoto
Daisuke Murakami
Masakazu Fujimoto
Hiroki Yamaue
Publication date
01-04-2019
Publisher
Springer Singapore
Published in
International Cancer Conference Journal / Issue 2/2019
Electronic ISSN: 2192-3183
DOI
https://doi.org/10.1007/s13691-018-00355-1

Other articles of this Issue 2/2019

International Cancer Conference Journal 2/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine